 microfoam compared with
surgery or sclerotherapy in the management of varicose veins in the
presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006;21:180-90.
326. Regan JD, Gibson KD, Rush JE, Shortell CK, Hirsch SA, Wright DD.
Clinical significance of cerebrovascular gas emboli during polidocanol
endovenous ultra-low nitrogen microfoam ablation and correlation
with magnetic resonance imaging in patients with right-to-left shunt.
J Vasc Surg 2011;53:131-70.
327. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T,
Johnson E, et al. Comparisons of side effects using air and carbon
dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:
830-6.
328. Chant AD, Jones HO, Weddell JM. Varicose veins: a comparison of
surgery and injection-compression sclerotherapy. Lancet 1972;2:
1188-91.
329. Kern P, Ramelet AA, WÃ¼tschert R, Hayoz D. Compression after
sclerotherapy for telangiectasias and reticular leg veins: a randomized
controlled study. J Vasc Surg 2007;45:1212-6.
330. Goldman MP. Treatment of varicose and telangiectatic leg veins:
double-blind prospective comparative trial between aethoxyskerol and
sotradecol. Dermatol Surg 2002;28:52-5.
331. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great
saphenous vein sclerotherapy using standardised polidocanol foam
(ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc
Endovasc Surg 2008;35:238-45.
332. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided
